References
- Akbaba, Y., Türkeş, C., Polat, L., Söyüt, H., Sahin, E., Menzek, A., Göksu, S., & Beydemir, S. (2013). Synthesis and paroxonase activities of novel bromophenols. Journal of Enzyme Inhibition and Medicinal Chemistry, 28(5), 1073–1079. https://doi.org/https://doi.org/10.3109/14756366.2012.715287
- Anglister, L., Etlin, A., Finkel, E., Durrant, A. R., & Lev-Tov, A. (2008). Cholinesterases in development and disease. Chemico-Biological Interactions, 175(1-3), 92–100. https://doi.org/https://doi.org/10.1016/j.cbi.2008.04.046
- Anwar, J., Spanevello, R. M., Thomé, G., Stefanello, N., Schmatz, R., Gutierres, J., Vieira, J., Baldissarelli, J., Carvalho, F. B., da Rosa, M. M., Rubin, M. A., Fiorenza, A., Morsch, V. M., & Schetinger, M. R. C. (2012). Effects of caffeic acid on behavioral parameters and on the activity of acetylcholinesterase in different tissues from adult rats. Pharmacology Biochemistry and Behavior, 103(2), 386–394. https://doi.org/https://doi.org/10.1016/j.pbb.2012.09.006
- Balasundram, N., Sundram, K., & Samman, S. (2006). Phenolic compounds in plants and agri-industrial by-products: Antioxidant activity, occurrence, and potential uses. Food Chemistry, 99(1), 191–203. https://doi.org/https://doi.org/10.1016/j.foodchem.2005.07.042
- Barclay, L. R. C., Vinqvist, M. R., Mukai, K., Itoh, S., & Morimoto, H. (1993). Chain-breaking phenolic antioxidants: Steric and electronic effects in polyalkylchromanols, tocopherol analogs, hydroquinones, and superior antioxidants of the polyalkylbenzochromanol and naphthofuran class. The Journal of Organic Chemistry, 58(26), 7416–7420. https://doi.org/https://doi.org/10.1021/jo00078a020
- Beydemir, Ş., Türkeş, C., & Yalçın, A. (2019). Gadolinium-based contrast agents: In vitro paraoxonase 1 inhibition, in silico studies. Drug and Chemical Toxicology, 1–10. https://doi.org/https://doi.org/10.1080/01480545.2019.1620266
- Burda, S., & Oleszek, W. (2001). Antioxidant and antiradical activities of flavonoids. Journal of Agricultural and Food Chemistry, 49(6), 2774–2779. https://doi.org/https://doi.org/10.1021/jf001413m
- Butterfield, D. A., & Lauderback, C. M. (2002). Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: Potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radical Biology & Medicine, 32(11), 1050–1060. https://doi.org/https://doi.org/10.1016/s0891-5849(02)00794-3
- Cheng, C.-Y., Su, S.-Y., Tang, N.-Y., Ho, T.-Y., Chiang, S.-Y., & Hsieh, C.-L. (2008). Ferulic acid provides neuroprotection against oxidative stress-related apoptosis after cerebral ischemia/reperfusion injury by inhibiting ICAM-1 mRNA expression in rats. Brain Research, 1209, 136–150. https://doi.org/https://doi.org/10.1016/j.brainres.2008.02.090
- Cheng, J.-C., Dai, F., Zhou, B., Yang, L., & Liu, Z.-L. (2007). Antioxidant activity of hydroxycinnamic acid derivatives in human low density lipoprotein: Mechanism and structure–activity relationship. Food Chemistry, 104(1), 132–139. https://doi.org/https://doi.org/10.1016/j.foodchem.2006.11.012
- Cheung, J., Rudolph, M. J., Burshteyn, F., Cassidy, M. S., Gary, E. N., Love, J., Franklin, M. C., & Height, J. J. (2012). Structures of human acetylcholinesterase in complex with pharmacologically important ligands. Journal of Medicinal Chemistry, 55(22), 10282–10286. https://doi.org/https://doi.org/10.1021/jm300871x
- Christen, Y. (2000). Oxidative stress and Alzheimer disease. The American Journal of Clinical Nutrition, 71(2), 621S–629S. https://doi.org/https://doi.org/10.1093/ajcn/71.2.621s
- Collins, P., Rosano, G. M. C., Sarrel, P. M., Ulrich, L., Adamopoulos, S., Beale, C. M., McNeill, J. G., & Poole-Wilson, P. A. (1995). 17β-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation, 92(1), 24–30. https://doi.org/https://doi.org/10.1161/01.CIR.92.1.24
- Demir, Y. (2019). The behaviour of some antihypertension drugs on human serum paraoxonase-1: An important protector enzyme against atherosclerosis. The Journal of Pharmacy and Pharmacology, 71(10), 1576–1583. https://doi.org/https://doi.org/10.1111/jphp.13144
- Demir, Y. (2020). Naphthoquinones, benzoquinones, and anthraquinones: Molecular docking, ADME and inhibition studies on human serum paraoxonase‐1 associated with cardiovascular diseases. Drug Development Research. https://doi.org/https://doi.org/10.1002/ddr.21667
- Demir, Y., Işık, M., Gülçin, İ., & Beydemir, Ş. (2017). Phenolic compounds inhibit the aldose reductase enzyme from the sheep kidney. Journal of Biochemical and Molecular Toxicology, 31(9), e21936. https://doi.org/https://doi.org/10.1002/jbt.21935
- Demir, Y., Türkeş, C., & Beydemir, Ş. (2020). Molecular docking studies and inhibition properties of some antineoplastic agents against paraoxonase-I. Anti-Cancer Agents in Medicinal Chemistry, 20(7), 887–896. https://doi.org/https://doi.org/10.2174/1871520620666200218110645
- Durgun, M., Türkeş, C., Işık, M., Demir, Y., Saklı, A., Kuru, A., Güzel, A., Beydemir, Ş., Akocak, S., Osman, S. M., AlOthman, Z., & Supuran, C. T. (2020). Synthesis, characterization, biological evaluation and in silico studies of sulfonamide Schiff bases. Journal of Enzyme Inhibition and Medicinal Chemistry, 35(1), 950–962. https://doi.org/https://doi.org/10.1080/14756366.2020.1746784
- Ellman, G. L., Courtney, K. D., Andres, V., & Feather-Stone, R. M. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology, 7(2), 88–95. https://doi.org/https://doi.org/10.1016/0006-2952(61)90145-9
- Giacobini, E. (2004). Cholinesterase inhibitors: New roles and therapeutic alternatives. Pharmacological Research, 50(4), 433–440. https://doi.org/https://doi.org/10.1016/j.phrs.2003.11.017
- Gülcin, I. (2012). Antioxidant activity of food constituents: An overview. Archives of Toxicology, 86(3), 345–391. https://doi.org/https://doi.org/10.1007/s00204-011-0774-2
- Gündoğdu, S., Türkeş, C., Arslan, M., Demir, Y., & Beydemir, Ş. (2019). New isoindole‐1, 3‐dione substituted sulfonamides as potent inhibitors of carbonic anhydrase and acetylcholinesterase: Design, synthesis, and biological evaluation. ChemistrySelect, 4(45), 13347–13355. https://doi.org/https://doi.org/10.1002/slct.201903458
- Ha, S. (2002). Asetilkolin, kolinesterazlar ve Alzheimer hastalığı. Demans Dergisi, 2, 69–73.
- Işık, M., Beydemir, Ş., Yılmaz, A., Naldan, M. E., Aslan, H. E., & Gülçin, İ. (2017). Oxidative stress and mRNA expression of acetylcholinesterase in the leukocytes of ischemic patients. Biomedicine & Pharmacotherapy, 87, 561–567. https://doi.org/https://doi.org/10.1016/j.biopha.2017.01.003
- Işık, M. (2019). The binding mechanisms and inhibitory effect of intravenous anesthetics on AChE in vitro and in vivo: Kinetic analysis and molecular docking. Neurochemical Research, 44(9), 2147–2155. https://doi.org/https://doi.org/10.1007/s11064-019-02852-y
- Işık, M. (2020). High stability of immobilized acetylcholinesterase on chitosan beads. ChemistrySelect, 5(15), 4623–4627. https://doi.org/https://doi.org/10.1002/slct.202000559
- Işık, M., Akocak, S., Lolak, N., Taslimi, P., Türkeş, C., Gülçin, İ., Durgun, M., & Beydemir, Ş. (2020). Synthesis, characterization, biological evaluation, and in silico studies of novel 1,3-diaryltriazene-substituted sulfathiazole derivatives. Archiv der Pharmazie, 353, e2000102. https://doi.org/https://doi.org/10.1002/ardp.202000102
- Işık, M., & Beydemir, Ş. (2019). AChE mRNA expression as a possible novel biomarker for the diagnosis of coronary artery disease and Alzheimer’s disease, and its association with oxidative stress. Archives of Physiology and Biochemistry, 1–8. https://doi.org/https://doi.org/10.1080/13813455.2019.1683584
- Işık, M., Beydemir, Ş., Demir, Y., Durgun, M., Türkeş, C., Nasır, A., Necip, A., & Akkuş, M. (2020). Benzenesulfonamide derivatives containing imine and amine groups: Inhibition on human paraoxonase and molecular docking studies. International Journal of Biological Macromolecules, 146, 1111–1123. https://doi.org/https://doi.org/10.1016/j.ijbiomac.2019.09.237
- Işık, M., Demir, Y., Durgun, M., Türkeş, C., Necip, A., & Beydemir, Ş. (2020). Molecular docking and investigation of 4-(benzylideneamino)-and 4-(benzylamino)-benzenesulfonamide derivatives as potent AChE inhibitors. Chemical Papers, 74(5), 1395–1405. https://doi.org/https://doi.org/10.1007/s11696-019-00988-3
- Isik, M., Korkmaz, M., Bursal, E., Gulcin, I., Koksal, E., & Tohma, H. (2015). Determination of antioxidant properties of Gypsophila bitlisensis Bark. International Journal of Pharmacology, 11(4), 366–337l. https://doi.org/https://doi.org/10.3923/ijp.2015.366.371
- Istrefi, Q., Türkeş, C., Arslan, M., Demir, Y., Nixha, A. R., Beydemir, Ş., & Küfrevioğlu, Ö. İ. (2020). Sulfonamides incorporating ketene N,S-acetal bioisosteres as potent carbonic anhydrase and acetylcholinesterase inhibitors. Archiv der Pharmazie, 353(6), 1900383. https://doi.org/https://doi.org/10.1002/ardp.201900383
- Kähkönen, M. P., Hopia, A. I., Vuorela, H. J., Rauha, J.-P., Pihlaja, K., Kujala, T. S., & Heinonen, M. (1999). Antioxidant activity of plant extracts containing phenolic compounds. Journal of Agricultural and Food Chemistry, 47(10), 3954–3962. https://doi.org/https://doi.org/10.1021/jf990146l
- Kakinuma, Y., Furihata, M., Akiyama, T., Arikawa, M., Handa, T., Katare, R. G., & Sato, T. (2010). Donepezil, an acetylcholinesterase inhibitor against Alzheimer’s dementia, promotes angiogenesis in an ischemic hindlimb model. Journal of Molecular and Cellular Cardiology, 48(4), 680–693. https://doi.org/https://doi.org/10.1016/j.yjmcc.2009.11.010
- Kwon, S.-H., Lee, H.-K., Kim, J.-A., Hong, S.-I., Kim, H.-C., Jo, T.-H., Park, Y.-I., Lee, C.-K., Kim, Y.-B., Lee, S.-Y., & Jang, C.-G. (2010). Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via anti-acetylcholinesterase and anti-oxidative activities in mice. European Journal of Pharmacology, 649(1-3), 210–217. https://doi.org/https://doi.org/10.1016/j.ejphar.2010.09.001
- Legrand, S., Nordlander, G., Nordenhem, H., Borg-Karlsonc, A.-K., & Uneliusa, C. R. (2004). Hydroxy-methoxybenzoic methyl esters: Synthesis and antifeedant activity on the pine weevil, Hylobius abietis. Zeitschrift für Naturforschung B, 59(7), 829–835. https://doi.org/https://doi.org/10.1515/znb-2004-0714
- Lolak, N., Akocak, S., Türkeş, C., Taslimi, P., Işık, M., Beydemir, Ş., Gülçin, İ., & Durgun, M. (2020). Synthesis, characterization, inhibition effects, and molecular docking studies as acetylcholinesterase, α-glycosidase, and carbonic anhydrase inhibitors of novel benzenesulfonamides incorporating 1,3,5-triazine structural motifs. Bioorganic Chemistry, 100, 103897. https://doi.org/https://doi.org/10.1016/j.bioorg.2020.103897
- Mattila, P., & Kumpulainen, J. (2002). Determination of free and total phenolic acids in plant-derived foods by HPLC with diode-array detection. Journal of Agricultural and Food Chemistry, 50(13), 3660–3667. https://doi.org/https://doi.org/10.1021/jf020028p
- Moure, A., Cruz, J. M., Franco, D., Domı́nguez, J. M., Sineiro, J., Domı́nguez, H., José Núñez, M., & Parajó, J. C., (2001). Natural antioxidants from residual sources. Food Chemistry, 72(2), 145–171. https://doi.org/https://doi.org/10.1016/S0308-8146(00)00223-5
- Oboh, G., Agunloye, O. M., Akinyemi, A. J., Ademiluyi, A. O., & Adefegha, S. A. (2013). Comparative study on the inhibitory effect of caffeic and chlorogenic acids on key enzymes linked to Alzheimer’s disease and some pro-oxidant induced oxidative stress in rats’ brain-in vitro. Neurochemical Research, 38(2), 413–419. https://doi.org/https://doi.org/10.1007/s11064-012-0935-6
- Praticò, D., & Delanty, N. (2000). Oxidative injury in diseases of the central nervous system: Focus on Alzheimer’s disease. The American Journal of Medicine, 109(7), 577–585. https://doi.org/https://doi.org/10.1016/s0002-9343(00)00547-7
- Rao, A. A., Sridhar, G. R., & Das, U. N. (2007). Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer’s disease. Medical Hypotheses, 69(6), 1272–1276. https://doi.org/https://doi.org/10.1016/j.mehy.2007.03.032
- Robbins, R. J. (2003). Phenolic acids in foods: An overview of analytical methodology. Journal of Agricultural and Food Chemistry, 51(10), 2866–2887. https://doi.org/https://doi.org/10.1021/jf026182t
- Sabbagh, M. N., Farlow, M. R., Relkin, N., & Beach, T. G. (2006). Do cholinergic therapies have disease-modifying effects in Alzheimer’s disease? Alzheimer’s & Dementia, 2(2), 118–125. https://doi.org/https://doi.org/10.1016/j.jalz.2006.02.001
- Scozzafava, A., Kalın, P., Supuran, C. T., Gülçin, İ., & Alwasel, S. H. (2015). The impact of hydroquinone on acetylcholine esterase and certain human carbonic anhydrase isoenzymes (hCA I, II, IX, and XII). Journal of Enzyme Inhibition and Medicinal Chemistry, 30(6), 941–946. https://doi.org/https://doi.org/10.3109/14756366.2014.999236
- Szwajgier, D. (2013). Anticholinesterase activity of phenolic acids and their derivatives. Zeitschrift für Naturforschung C, 68(3-4), 125–132. https://doi.org/https://doi.org/10.1515/znc-2013-3-408
- Takım, K., & Işık, M. (2020). Phytochemical analysis of Paliurus spina-christi fruit and its effects on oxidative stress and antioxidant enzymes in streptozotocin-induced diabetic rats. Applied Biochemistry and Biotechnology, 1–16. https://doi.org/https://doi.org/10.1007/s12010-020-03287-w
- Taslimi, P., Işık, M., Türkan, F., Durgun, M., Türkeş, C., Gülçin, İ., Beydemir, Ş. (2020). Benzenesulfonamide derivatives as potent acetylcholinesterase, α-glycosidase, and glutathione S-transferase inhibitors: Biological evaluation and molecular docking studies. Journal of Biomolecular Structure and Dynamics, 1–12. https://doi.org/10.1080/07391102.2020.1790422
- Taslimi, P., Kandemir, F. M., Demir, Y., İleritürk, M., Temel, Y., Caglayan, C., & Gulçin, İ. (2019). The antidiabetic and anticholinergic effects of chrysin on cyclophosphamide-induced multiple organ toxicity in rats: Pharmacological evaluation of some metabolic enzyme activities . Journal of Biochemical and Molecular Toxicology, 33(6), e22313. https://doi.org/1002/jbt.22313 https://doi.org/https://doi.org/10.1002/jbt.22313
- Thacker, P. D. (2003). Surprising discovery with Alzheimer's medication. Drug Discovery Today, 8(9), 379–380. https://doi.org/https://doi.org/10.1016/S1359-6446(03)02685-0
- Türkeş, C. (2019a). Inhibition effects of phenolic compounds on human serum paraoxonase-1 enzyme. Journal of the Institute of Science and Technology, 9(2), 1013–1022. https://doi.org/https://doi.org/10.21597/jist.491054
- Türkeş, C. (2019b). Investigation of potential paraoxonase-I inhibitors by kinetic and molecular docking studies: Chemotherapeutic drugs. Protein & Peptide Letters, 26(6), 392–402. https://doi.org/https://doi.org/10.2174/0929866526666190226162225
- Türkeş, C. (2019c). A potential risk factor for paraoxonase 1: In silico and in-vitro analysis of the biological activity of proton-pump inhibitors . The Journal of Pharmacy and Pharmacology, 71(10), 1553–1564. https://doi.org/https://doi.org/10.1111/jphp.13141
- Türkeş, C., Arslan, M., Demir, Y., Çoçaj, L., Rifati Nixha, A., & Beydemir, Ş. (2019). Synthesis, biological evaluation and in silico studies of novel N-substituted phthalazine sulfonamide compounds as potent carbonic anhydrase and acetylcholinesterase inhibitors. Bioorganic Chemistry, 89, 103004. https://doi.org/https://doi.org/10.1016/j.bioorg.2019.103004
- Türkeş, C., & Beydemir, Ş. (2020). Inhibition of human serum paraoxonase-I with antimycotic drugs: In vitro and in silico Studies. Biotechnology and Applied Biochemistry, 190(1), 252–269. https://doi.org/https://doi.org/10.1007/s12010-019-03073-3
- Türkeş, C., Beydemir, Ş., & Küfrevioğlu, Ö. İ. (2019). In vitro and in silico studies on the toxic effects of antibacterial drugs as human serum paraoxonase 1 inhibitor. ChemistrySelect, 4(33), 9731–9736. https://doi.org/https://doi.org/10.1002/slct.201902424
- Türkeş, C., Demir, Y., & Beydemir, Ş. (2019). Anti-diabetic properties of calcium channel blockers: Inhibition effects on aldose reductase enzyme activity. Applied Biochemistry and Biotechnology, 189(1), 318–329. https://doi.org/https://doi.org/10.1007/s12010-019-03009-x
- Türkeş, C., Demir, Y., & Beydemir, Ş. (2020). Calcium channel blockers: Molecular docking and inhibition studies on carbonic anhydrase I and II isoenzymes. Journal of Biomolecular Structure and Dynamics, 1–15. https://doi.org/https://doi.org/10.1080/07391102.2020.1736631
- Türkeş, C., Söyüt, H., & Beydemir, Ş. (2013). Inhibition effects of gemcitabine hydrochloride, acyclovir, and 5-fluorouracil on human serum paraoxonase-1 (hPON1): In vitro. Open Journal of Biochemistry, 1, 10–15. https://doi.org/https://doi.org/10.15764/BIOC.2014.01002
- Türkeş, C., Söyüt, H., & Beydemir, Ş. (2014). Effect of calcium channel blockers on paraoxonase-1 (PON1) activity and oxidative stress. Pharmacological Reports, 66(1), 74–80. https://doi.org/https://doi.org/10.1016/j.pharep.2013.08.007
- Türkeş, C., Söyüt, H., & Beydemir, Ş. (2015). Human serum paraoxonase-1 (hPON1): In vitro inhibition effects of moxifloxacin hydrochloride, levofloxacin hemihidrate, cefepime hydrochloride, cefotaxime sodium and ceftizoxime sodium. Journal of Enzyme Inhibition and Medicinal Chemistry, 30(4), 622–628. https://doi.org/https://doi.org/10.3109/14756366.2014.959511
- Türkeş, C., Söyüt, H., & Beydemir, Ş. (2016). In vitro inhibitory effects of palonosetron hydrochloride, bevacizumab and cyclophosphamide on purified paraoxonase-I (hPON1) from human serum. Environmental Toxicology and Pharmacology, 42, 252–257. https://doi.org/https://doi.org/10.1016/j.etap.2015.11.024
- Wright, D. L., & Plummer, D. T. (1973). Multiple forms of acetylcholinesterase from human erythrocytes. The Biochemical Journal, 133(3), 521–527. https://doi.org/https://doi.org/10.1042/bj1330521
- Yamali, C., Gul, H. I., Ece, A., Taslimi, P., & Gulcin, I. (2018). Synthesis, molecular modeling, and biological evaluation of 4‐[5‐aryl‐3‐(thiophen‐2‐yl)‐4, 5‐dihydro‐1H‐pyrazol‐1‐yl] benzenesulfonamides toward acetylcholinesterase, carbonic anhydrase I and II enzymes. Chemical Biology & Drug Design, 91(4), 854–866. https://doi.org/https://doi.org/10.1111/cbdd.13149
- Yan, J. J., Cho, J. Y., Kim, H. S., Kim, K. L., Jung, J. S., Huh, S. O., Suh, H. W., Kim, Y. H., & Song, D. K. (2001). Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. British Journal of Pharmacology, 133(1), 89–96. https://doi.org/https://doi.org/10.1038/sj.bjp.0704047